Evidence map›Paper›PMID 37075055›Full record

ArticlePloS one2023

How much behaviour change is required for the investment in cycling infrastructure to be sustainable? A break-even analysis.

Paolo Candio, Emma Frew

Abstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Paolo CandioDepartment of Economics and Management, University of Trento, Trento, Italy.ORCID 0000-0003-1521-088X
Emma FrewCentre for Economics of Obesity, Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.

Funding

Department of Health NIHR300773
6 · The paper itself

Abstract

backgroundActive travel has gained traction among policy makers as a promising solution to physical inactivity. Returns on active travel investments, including cycling infrastructure, crucially rely on resulting improvements in population behaviours. Estimating the expected economic value that an additional regular cyclist will generate and being able to identify the behaviour change required at the population level to offset the intervention costs is important to inform future investment decisions.

methodsThe WHO's Health Economic Assessment Tool was employed to conduct a break-even analysis. A case study methodology was used which focused on a real-world construction project of a separated cycleway in the UK. The economic assessment considered physical activity benefits, air pollution, crash risk and carbon emissions in monetary terms. An iterative computational approach was applied to identify the behaviour change (cycling) requirements, and corresponding benefits valued using international dollars, to break even on the investment costs. Sensitivity analyses were conducted to assess robustness of the base-case results.

resultsOver a ten-year time horizon, an additional regular cyclist (i.e., someone cycling most days of the week) was found to generate $798 (₤533) per annum (international dollars). An additional 267 regular cyclists per km were required to break even on the construction of the new separated cycleway. Estimates were particularly sensitive to variations to age, cycling volume and evaluation time horizon.

conclusionsPolicymakers planning to invest in cycling infrastructure should consider using these reproducible, order-of-magnitude estimates to complement the more comprehensive transport appraisal and budget allocation processes. This would ensure that, when considering its health-related economic benefits, the investment is justifiable on economic sustainability grounds.

Indexed as

Air PollutionBicyclingCost-Benefit AnalysisHumansInvestments

Identifiers

PMID37075055
PMCPMC10115289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.